L-citrulline ameliorates chronic hypoxia-induced pulmonary hypertension in newborn piglets

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 297, Issue 3, 2009, Pages

  Ananthakrishnan, Madhumita ^a   Barr, Frederick E ^a   Summar, Marshall L ^a   Smith, Heidi A ^a   Kaplowitz, Mark ^a   Cunningham, Gary ^a   Magarik, Jordan ^a   Zhang, Yongmei ^a   Fike, Candice D ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b 1125 MRB IV/Light Hall   (United States)

Author keywords

L arginine recycling; Nitric oxide; Nitric oxide synthase

Indexed keywords

ARGININE; CITRULLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRATE; NITRIC OXIDE; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART OUTPUT; HYPOXIA; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG PERFUSION; LUNG VASCULAR RESISTANCE; NEWBORN; NONHUMAN; PIGLET; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

AMINO ACIDS; ANIMALS; ANIMALS, NEWBORN; ANOXIA; BLOTTING, WESTERN; CHRONIC DISEASE; CITRULLINE; EXHALATION; HEMODYNAMICS; HYPERTENSION, PULMONARY; LUNG; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE III; PERFUSION; PRESSURE; PULMONARY ARTERY; SUS SCROFA;

EID: 68949132838     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00017.2009     Document Type: Article

References (36)

1. Abman SH. Monitoring cardiovascular function in infants with chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed 87: F15-F18, 2002.
2. Allen J, subcommittee AoP ATS. Statement on the care of the child with chronic lung disease of infancy and childhood. Am J Respir Crit Care Med 168: 356-396, 2003.
3. Aschner J. New therapies for pulmonary hypertension in neonates and children. Pediatric Pulmonol 26S: S132-S135, 2004.
4. Barr FE, Tirona RG, Taylor MB, Rice G, Arnold J, Cunningham G, Smith HA, Campbell A, Canter JA, Christian KG, Drinkwater DC, Scholl F, Kavanaugh-McHugh A, Summar ML. Pharmacokinetics and safety of intravenously administered citrulline in children undergoing congenital heart surgery:potential therapy for postoperative pulmonary hypertension. J Thorac Cardiovasc Surg 134: 319-326, 2007.
5. Boger RH. L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous? Curr Opin Clin Nutr and Met Care 11: 55-61, 2008.
6. Boger RH, Bode-Boger SM, Heinzel D. Differential systemic and pulmonary haemodynamic effects of L-arginine in patients with coronary heart disease and primary pulmonary hypertension. Int Clin Pharmacol Ther 34: 323-328, 1996.
7. Dragoni S, Gori Stolfo GD T, Sicuro S, Forconi Parker JD S. Folic acid does not limit endothelial dysfunction induced by ischemia and reperfusion. J Cardiovasc Pharmacol 46: 494-497, 2005.
8. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 338: 1546-1550, 1991.
9. Fike CD, Kaplowitz MR. Effect of chronic hypoxia on pulmonary vascular pressures in isolated lungs of newborn pigs. J Appl Physiol 77: 2853-2862, 1994.
10. Fike CD, Kaplowitz MR, Rehorst-Paea LA, Nelin LD. L-Arginine increases nitric oxide production in isolated lungs of chronically hypoxic newborn pigs. J Appl Physiol 88: 1797-1803, 2000.
11. Fike CD, Kaplowitz MR, Thomas CJ, Nelin LD. Chronic hypoxia decreases nitric oxide production and endothelial nitric oxide synthase in newborn pig lungs. Am J Physiol Lung Cell Mol Physiol 274: L517-L526, 1998.
12. Flam BR, Hartmann PJ, Harrell-Booth M, Solomonson LP, Eichler DC. Caveolar localization of arginine regeneration enzymes, argininosuccinate synthase, and lyase, with endothelial nitric oxide synthase. Nitric Oxide 5: 187-197, 2001.
13. Goodwin BL, Solomonson LP, Eichler DC. Argininosuccinate synthase expression is required to maintain nitric oxide production and cell viability in aortic endothelial cells. J Biol Chem 279: 18353-18360, 2004.
14. Haworth SG, Hislop AA. Adaptation of the pulmonary circulation to extra-uterine life in the pig and its relevance to the human infant. Cardiovasc Res 15: 108-119, 1981.
15. Haworth SG, Hislop AA. Effect of hypoxia on adaptation of the pulmonary circulation to extra-uterine life in the pig. Cardiovasc Res 16: 293-303, 1982.
16. Hayashi T, Juliet PAR, Matsui-Hirai H, Miyazaki A, Fukatsu A, Funami J, Iguchi A, Ignarro LJ. L-Citrulline and L-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits. Proc Natl Acad Sci USA 102: 13681-13686, 2005.
17. Hecker Sessa WC M, Harris HJ, Anggard EE, Vane JR. The metabolism of L-arginine and its significance for the biosynthesis of endotheliumderived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine. Proc Natl Acad Sci USA 87: 8612-8616, 1990.
18. Koeners MP, Van Faassen EE, Wesseling S, Sain-van der Velden M, Koomans HA, Braam B, Joles JA. Maternal supplementation with citrulline increases renal nitric oxide in young spontaneously hypertensive rats and has long-term antihypertensive effects. Hypertension 50: 1077-1084, 2007.
19. phox). Am J Physiol Lung Cell Mol Physiol 290: L2-L10, 2006.
20. Mehta S, Stewart DJ, Langleben D, Levy RD. Short-term pulmonary vasodilation with L-arginine in pulmonary hypertension. Circulation 92:1539-1545, 1995.
21. Meier U. A note on the power of Fisher's least significant difference procedure. Pharm Stat 5: 253-263, 2006.
22. Mitani Y, Maruyama K, Minoru S. Prolonged administration of Larginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats. Circulation 96: 689-697, 1997.
23. Mupanemunda RH. Current status of inhaled nitric oxide therapy in the perinatal period. Early Hum Dev 47: 247-262, 1997.
24. Pernow J, Bohm F, Beltran E, Gonon A. L-Arginine protects from ischemia-reperfusion-induced endothelial dysfunction in humans in vivo. J Appl Physiol 95: 2218-2222, 2003.
25. Sasaki S, Asano M, Ukai T, Nomura N, Maruyama K, Manabe T, Mishima A. Nitric oxide formation and plasma L-arginine levels in pulmonary hypertensive rats. Respir Med 98: 205-212, 2004.
26. Schulman SP, Becker LC, Kass DA, Champion HC, Terrin ML, Forman S, Ernst KV, Kelemen MD, Townsend SN, Capriotti A, Hare JM, Gerstenblith G. L-Arginine therapy in acute myocardial infarction: the vascular interaction with age in myocardial infarction (VINTAGE MI) randomized clinical trial. JAMA 295: 58-64, 2006.
27. Schulze-Neick I, Penny DJ, Rigby ML, Morgan C, Kelleher A, Collins P, Li J,Bush A, Shinebourne EA, Redington AN. L-Arginine and substance P reverse the pulmonary endothelial dysfunction caused by congenital heart surgery. Circulation 100: 749-755, 1999.
28. Shimoda L, Sham JSK, Sylvester JT. Altered pulmonary vasoreactivity in the chronically hypoxic lung. Physiol Res 49: 549-560, 2000.
29. Smith HAB, Canter JA, Christian KG, Drinkwater DC, Scholl FG, Christman BW, Rice GD, Barr FE, Summar ML. Nitric oxide precursors and congenital heart surgery: a randomized controlled trial of oral citrulline. J Thorac Cardiovasc Surg 132: 58-65, 2006.
30. Solomonson LP, Flam BR, Pendleton LC, Goodwin BL, Eichler DC. The caveolar nitric oxide synthase/arginine regeneration system for NO production in endothelial cells. J Exp Biol 206: 2083-2087, 2003.
31. Subhedar NV. Recent advances in diagnosis and management of pulmonary hypertension in chronic lung disease. Acta Paediatr Suppl 444: 29-32, 2004.
32. Su Y, Block ER. Acute hypoxia increases intracellular L-arginine content in cultured porcine pulmonary artery endothelial cells. J Cell Physiol 167: 349-353, 1996.
33. Tenenbaum A, Fisman EZ, Motro M. L-Arginine: rediscovery in progress. Cardiology 90: 153-159, 1998.
34. Turley JE, Nelin LD, Kaplowitz MR, Zhang Y, Fike CD. Exhaled NO is reduced at an early stage of hypoxia-induced pulmonary hypertension in newborn piglets. Am J Physiol Lung Cell Mol Physiol 284: L489-L500, 2003.
35. Verma S, Maitland A, Weisel RD, Fedak PWM, Pomroy NC, Li SH, Mickle DAG, Li RK, Rao V. Novel cardioprotective effects of tetrahydrobiopterin after anoxia and reoxygenation: identifying cellular targets for pharmacologic manipulation. J Thorac Cardiovasc Surg 123: 1074-1083, 2002.
36. Waugh WH, Daeschner CWIII, Files BA, McConnell ME, Strandjord SE. Oral citrulline as arginine precursor may be beneficial in sickle cell disease: early phase two results. J Natl Med Assoc 93: 363-371, 2001.